gatifloxacin has been researched along with Psychoses, Drug in 2 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Satyanarayana, S | 1 |
Campbell, B | 1 |
Palmer, TR | 1 |
2 other studies available for gatifloxacin and Psychoses, Drug
Article | Year |
---|---|
Gatifloxacin-induced delirium and psychosis in an elderly demented woman.
Topics: Aged, 80 and over; Anti-Infective Agents; Delirium; Dementia; Female; Fluoroquinolones; Gatifloxacin | 2006 |
Delirium was likely due to multiple factors, rather than gatifloxacin induced.
Topics: Aged, 80 and over; Anti-Infective Agents; Delirium; Dementia; Female; Fluoroquinolones; Gatifloxacin | 2006 |